CellGenix GmbH is a biopharmaceutical company active in the field of cellular therapies and regenerative medicine. CellGenix was founded in 1994 and is located in Freiburg, Germany. The company develops, manufactures and markets cell therapy products and high-quality reagents for ex vivo cell culture. CellGenix is a leading supplier of GMP (Good Manufacturing Practice) manufactured cytokines and serum-free media for cell therapy applications worldwide. As the first European company to obtain a GMP manufacturing authorization for cell processing in Europe CellGenix continues to build on more than 15 years of in-house experience in clinical cell therapies.
Today, CellGenix’ fully owned subsidiary Metreon Bioproducts GmbH continues to provide GMP allogeneic cord blood stem cells and CartiGro® autologous chondrocytes to our cooperation and distribution partners. Our products are used by leading experts and proven in clinical trials throughout the world. With the unique background in GMP manufacturing of both cell therapy products and recombinant protein pharmaceuticals and the track record in clinical application CellGenix is ideally positioned to become
Your Partner for Clinical Cell Therapy.
Learn more: » GMP-Facility and Manufacturing Excellence